Oncostatin M:: Signal transduction and biological activity

被引:82
作者
Gómez-Lechón, MJ [1 ]
机构
[1] Hosp Univ La Fe, Unidad Hepatol Expt, Ctr Investigac, Valencia 46009, Spain
关键词
acute-phase; oncostatin M; cell growth; cell differentiation; CYP; cytokines; JAK; STAT;
D O I
10.1016/S0024-3205(99)00296-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oncostatin M (OSM) is a multifunctional cytokine produced by activated T lymphocytes and monocytes that is structurally and functionally related to the subfamily of cytokines known as the IL-6-type cytokine family. OSM shares properties with all members of this family of cytokines, but is most closely related structurally and functionary to LIE OSM acts on a wide variety of cells and elicits diversified biological responses in vivo and in vitro which suggest potential roles in the regulation of gene activation, cell survival, proliferation and differentiation. OSM and LIF can bind to the same functional receptor complex (LIF-receptor beta and gp130 heteromultidimers) and thus mediate overlapping spectra of biological activities. There is a second specific beta receptor that binds OSM with high affinity and also involves the subunit gp130. The two receptors for OSM can be functionally different and be coupled to different signal transduction pathways. OSM-specific receptors are expressed in a wide variety of cell types and do not possess an intrinsic tyrosine kinase domain, but the JAK/STAT tyrosine kinase pathway mediates signal transduction.
引用
收藏
页码:2019 / 2030
页数:12
相关论文
共 109 条
[61]   Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells [J].
Liu, JW ;
Hadjokas, N ;
Mosley, B ;
Estrov, Z ;
Spence, MJ ;
Vestal, RE .
CYTOKINE, 1998, 10 (04) :295-302
[62]  
LIU JW, 1992, J BIOL CHEM, V267, P16763
[63]  
Liu JW, 1997, J LIPID RES, V38, P2035
[64]   Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways [J].
Luo, H ;
Rose, P ;
Barber, D ;
Hanratty, WP ;
Lee, S ;
Roberts, TM ;
DAndrea, AD ;
Dearolf, CR .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (03) :1562-1571
[65]   MOLECULAR-CLONING, SEQUENCE-ANALYSIS, AND FUNCTIONAL EXPRESSION OF A NOVEL GROWTH-REGULATOR, ONCOSTATIN-M [J].
MALIK, N ;
KALLESTAD, JC ;
GUNDERSON, NL ;
AUSTIN, SD ;
NEUBAUER, MG ;
OCHS, V ;
MARQUARDT, H ;
ZARLING, JM ;
SHOYAB, M ;
WEI, CM ;
LINSLEY, PS ;
ROSE, TM .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) :2847-2853
[66]   ONCOSTATIN-M AS A POTENT MITOGEN FOR AIDS-KAPOSIS SARCOMA DERIVED CELLS [J].
MILES, SA ;
MARTINEZMAZA, O ;
REZAI, A ;
MAGPANTAY, L ;
KISHIMOTO, T ;
NAKAMURA, S ;
RADKA, SF ;
LINSLEY, PS .
SCIENCE, 1992, 255 (5050) :1432-1434
[67]   DOWN-REGULATION OF MULTIPLE CYTOCHROME-P450 GENE-PRODUCTS BY INFLAMMATORY MEDIATORS INVIVO - INDEPENDENCE FROM THE HYPOTHALAMOPITUITARY AXIS [J].
MORGAN, ET .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) :415-419
[68]   Dual oncostatin M (OSM) receptors - Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation [J].
Mosley, B ;
DeImus, C ;
Friend, D ;
Boiani, N ;
Thoma, B ;
Park, LS ;
Cosman, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32635-32643
[69]  
MUNTANERELAT J, 1995, HEPATOLOGY, V22, P1143
[70]  
MURAKAMI M, 1993, SCIENCE, V88, P1008